Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression [2] (multiple letters)

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1601-1603

  Tammemagi, C Martin ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-B1;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; GENE OVEREXPRESSION; HUMAN; LETTER; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; BIOSYNTHESIS; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; NOTE;

CARCINOMA, NON-SMALL-CELL LUNG; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; RIBONUCLEOPROTEINS;

EID: 0034171144     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)